PD for Mon 21 Oct 2024 - Major change coming for Tasmanian pharmacists, Priceline HPV screening plan under fire, Telix going big in the US, mRNA vaccine safety and much more
Tas legislation change coming for mainland prescriptions, GPs raise concern on Priceline cervical screening plan, TGA pushes back on mRNA vaccine safety reports
Pharmacy Daily - a division of Business Publishing Group PO Box 1010 Epping NSW Australia 1710 Level 2, Suite 1 64 Talavera Rd Macquarie Park NSW 2113 Tel: 1300 799 220 ( 61 2 8007 6760)
To ensure you continue to receive email from Pharmacy Daily reliably please add [email protected] to your 'Safe Senders' list and set images to always display. To forward this email to a friend click here To receive your own copy of Pharmacy Daily sign up here. To modify subscription details click here To unsubscribe click here. You are currently receiving the 'Attachment' version of Pharmacy Daily publications. To switch to a clickable link click here. The Therapeutic Goods (Therapeutic Goods Advertising) Instrument 2021 requires strict compliance. View the code at https://www.legislation.gov.au/Series/F2021L01661.
